Riskpilot← Back to searchSign inGet full accessPsycurum AB
ABActiveOrg 5566913421Hantverkargatan 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 20051 employees
Revenue 2025
SEK 1,9M
-31% vs 2024
EBITDA margin
94.2%
-26% vs 2024
Equity ratio
50.7%
Financial strength
Net profit 2025
SEK 1,1M
-29% vs 2024
| Revenue | SEK 1,9M | -31% |
| EBITDA | SEK 1,8M | -26% |
| Net profit | SEK 1,1M | -29% |
| Total assets | SEK 15M | +9% |
| Equity | SEK 7,6M | +14% |
| Employees | 1 | — |
Legal name
Psycurum AB
Org number
5566913421
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24 november 2005
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver sjukvård och konsultverksamhet inom medicin och juridik. Bolaget handlar med värdepapper, samt äger och förvaltar fastigheter.
Address
Hantverkargatan 10
Phone
+46704844812
Email
hans-peter.mofors@psycurum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 524 | 2 309 | 2 891 | 2 776 | 1 915 |
| Staff expenses | — | −350 | −334 | −253 | −68 |
| EBITDA | 1 971 | 1 621 | 2 336 | 2 428 | 1 803 |
| Depreciation & amort. | −162 | −174 | −185 | −188 | −219 |
| EBIT | 1 809 | 1 447 | 2 152 | 2 240 | 1 584 |
| Net financials | −97 | −134 | −249 | −262 | −285 |
| Profit before tax | 1 750 | 1 313 | 2 299 | 2 046 | 1 453 |
| Tax | −385 | −277 | −492 | −426 | −307 |
| Net profit | 1 365 | 1 035 | 1 807 | 1 619 | 1 146 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 225 | 9 947 | 11 859 | 13 795 | 14 968 |
| Equity | 2 755 | 3 607 | 5 226 | 6 651 | 7 587 |
| Long-term debt | 3 682 | 4 598 | 5 270 | 6 018 | 6 722 |
| Short-term debt | 947 | 901 | 917 | 749 | 436 |
| Total debt | 4 629 | 5 499 | 6 187 | 6 767 | 7 157 |
EBITDA margin
94.2%
This company
15.8%
Market median
+496% vs market
20212025
Equity ratio
50.7%
This company
38.2%
Market median
+33% vs market
20212025
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
59.8%
This company
8.1%
Market median
+638% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Psycurum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ivar Hans Peter Mofors | Chief Executive Officer | 0 companies |
| Johannes Alexander Ivar Mofors | Deputy Board Member | 0 companies |